Latest News Feed
With the global functional mushroom market projected to exceed $30+ billion and forecasted to grow at an estimated 9-12% CAGR, this strategic Bronx, New York distribution expansion positions CBDL to capture accelerating consumer demand, drive repeat retail velocity, and unlock scalable, high-margin revenue channels.
With the global pain management market projected to exceed $110 billion by 2030 and hemp-derived topical products continuing to post double-digit annual growth, CBD Life Sciences is accelerating its expansion into premium, high-traffic retail environments nationwide.
"Inside the explosive rise of a wellness company outpacing a $200B+ global market"
With the global pain-management market projected to surpass $93.9 billion by 2030 and topical analgesics growing at a 7.2% CAGR, CBDL positions itself for major East Coast expansion amid surging consumer demand for natural relief solutions.
With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market.
Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing segments in wellness and performance nutrition.
Dubai's luxury chocolate market-valued at over $1.5 billion and growing 6.8% annually-meets the $35 billion global mushroom supplement boom, creating a major new revenue stream for CBDL.
Strong consumer demand and rapid market adoption drive CBDL's beverage expansion as top-selling CBD Lemonade, Raspberry Lemonade, and Lavender Lemonade hit the shelves of Smoking Scholars in New York City - setting the stage for record-breaking revenue in Q4 and beyond.
With New York dispensaries projected to surpass $4.4 billion in annual sales by 2027, CBDL secures a transformative partnership poised to generate multi-million-dollar revenues and accelerate nationwide expansion.
Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies
The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale beverage distribution in sports stadiums nationwide.
"A shift to Schedule III could unlock a $30+ billion market, eliminate crippling 280E tax burdens, unleash institutional investment, and set the stage for explosive industry-wide growth."
NECANN New Jersey attracts over 5,000 industry leaders, features more than 200 exhibitors, and is ranked the 3rd largest B2B cannabis convention in the United States - positioning CBDL for unprecedented growth, revenue opportunities, and investor value.
Las Vegas CBD market projected to surpass $550 million by 2026, driven by tourism, retail, and wellness integration
U.S. CBD market projected to exceed $36 billion by 2032 as foot traffic rebounds in top-tier malls with over 122 million monthly U.S. shoppers - CBDL strategically positioned at the intersection of both trends
CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, wellness-focused viewers - unlocking massive revenue potential and long-term shareholder value in the booming CBD market.
Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively by 2028-fuel strong consumer demand and industry expansion.
CBDL Enters the $2.8 Billion Suppository Market with a First-of-Its-Kind Product - Tapping a High-Demand, Low-Competition Sector Poised for Transformational Growth
With Delta-8 product revenue continuing to climb, CBDL introduces a lab-tested gummy formulation to meet surging demand in a market projected to exceed $2.1 billion by 2026.
Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines
New manufacturing deal positions CBDL to tap into the $4.9 billion Latin American CBD market, unlocking major revenue growth and accelerating international expansion.
With the global CBD market expected to exceed $60 billion by 2030, and the mental wellness industry surging past $500 billion, CBD Life Sciences Inc. (OTC: CBDL) is strategically positioning itself at the center of two of the fastest-growing markets in modern health.
With the global wellness industry exploding past $7 trillion, CBDL positions itself at the intersection of CBD, mushrooms, and modern healing - delivering real results and red-hot returns.
The global functional mushroom market is projected to reach $19.3 billion by 2030, driven by cutting-edge research revealing their potential to enhance memory, nerve growth, and overall cognitive health.
The global sexual wellness market is projected to surpass $125 billion by 2026, with the supplement industry experiencing rapid growth as consumers seek natural solutions for enhanced performance and vitality.
CBDL Targets a Multi-Million Dollar Market as Tens of Thousands of Attendees Converge for Arizona's Hottest Motorcycle Event
The Global Functional Mushroom Market is Set to Surpass $19 Billion by 2030—CBDL Enters the Booming Industry with Premium Mushroom Capsules for Cognitive Enhancement, Immune Support & Longevity!
The functional mushroom industry is exploding, set to surpass $69 billion by 2028, and CBDL is seizing the moment-unlocking a massive revenue opportunity with its latest game-changing expansion.
Groupon, with over 22.5 million active users and generating more than $550 million in annual revenue, now features CBDL's top-tier wellness products, unlocking massive e-commerce potential and positioning the company for explosive growth in the booming CBD industry.
Company Reports 3.5 billion Share Reduction from the Authorization
With DoorDash projecting over $10 billion in 2025 revenue, CBD Life Sciences Inc. is set to tap into one of the fastest-growing delivery markets in the country, potentially unlocking a multi-million dollar revenue stream and driving a projected 30-40% increase in annual revenue for CBDL.
Walmart Marketplace saw a 60% year-over-year growth in gross merchandise volume, with third-party sellers accounting for over 50% of online sales, contributing to Walmart's e-commerce revenue surpassing $100 billion in 2024. This makes it a powerful platform for rapid brand growth and a game-changing opportunity for CBDL's breakthrough product line.
Demonstrating shareholder confidence, CBDL commits to repurchasing 10% of revenue quarterly.
Target Acquisition Valued at $10 Million with Projected 2025 Gross Revenue of $5 Million, Positioning CBDL for Explosive Growth in Nevada's Burgeoning Cannabis Market
Exploding with momentum: CBDL shatters records with 622% revenue growth in five months, propelling to a 1,405% year-to-date increase-a game-changer in the CBD industry.
Targeting a booming $6 billion U.S. edibles market with a projected $3 million in first-year revenue, CBDL delivers an innovative solution for Alzheimer's care.
Company is creating its own wine. Capitalizing on the projected $2.1 billion U.S. CBD-infused beverage market by 2025, CBDL positions itself at the forefront of innovation, unlocking immense revenue potential in the booming CBD alcohol sector.
With the potential for explosive profits in a $70 billion industry, CBDL's innovative product line and strategic market positioning stand ready to deliver unparalleled returns for shareholders, making this a true game changer in the Hemp market.
